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Friedreich’s ataxia (FRDA) is caused by the expan-
sion of GAA repeats located in the Frataxin (FXN)
gene. The GAA repeats continue to expand in FRDA
patients, aggravating symptoms and contributing
to disease progression. The mechanism leading to
repeat expansion and decreased FXN transcription
remains unclear. Using single-molecule analysis of
replicated DNA, we detected that expanded GAA
repeats present a substantial obstacle for the repli-
cation machinery at the FXN locus in FRDA cells.
Furthermore, aberrant origin activation and lack of
a proper stress response to rescue the stalled forks
in FRDA cells cause an increase in 30-50 progressing
forks, which could enhance repeat expansion and
hinder FXN transcription by head-on collision with
RNA polymerases. Treatment of FRDA cells with
GAA-specific polyamides rescues DNA replication
fork stalling and alleviates expansion of the GAA
repeats, implicating DNA triplexes as a replication
impediment and suggesting that fork stalling might
be a therapeutic target for FRDA.
INTRODUCTION
Friedreich’s ataxia (FRDA) is themost commonly inherited ataxia
in the Caucasian population. FRDA is an autosomal recessive
disease with an estimated prevalence of 1:29,000 and a carrier
frequency of about 1:100 (Delatycki et al., 2000). FRDA is
caused by a GAA repeat expansion in the first intron of the
Frataxin (FXN) gene. In affected individuals, the GAA repeat in-
creases from a normal range of 6–34 repeats to a pathogenic
range of 66–1,700 repeats (Campuzano et al., 1996). GAA repeat
expansion leads to decreased transcription of the FXN gene and
reduced expression of FXN, an iron-binding protein responsible
for biogenesis of iron-sulfur clusters (reviewed by Schmucker
and Puccio, 2010). Frataxin deficiency causes mitochondrial
iron overload, which severely impacts cardiomyocytes and neu-1218 Cell Reports 16, 1218–1227, August 2, 2016 ª 2016 The Author
This is an open access article under the CC BY-NC-ND license (http://rons (Koeppen, 2011). Progressive damage to the nervous sys-
tem leads to symptoms such as gait disturbance, vision and
hearing impairment, and speech difficulties. There is currently
no cure for this fatal disease. Expanded GAA repeats are in-
herited from both parents and expand further post-zygotically
in FRDA patients (De Biase et al., 2007; De Michele et al.,
1998). Recently, progressive GAA repeat expansions were
discovered in human induced pluripotent stem cells (iPSCs)
derived from FRDA fibroblasts (Ku et al., 2010), allowing for
analyses of the expansion mechanism in the natural context of
the FXN locus.
The mechanism for GAA repeat expansion in FRDA
patients remains ambiguous. GAA repeats are able to form un-
usual non-B DNA structures, such as triplexes, intramolecular
H-DNA, aswell as intermolecular sticky DNA (Wells, 2008), which
potentially could block the replication and transcription machin-
eries in patient cells. Expanded GAA repeats also form R-loops
in vitro and in vivo (Groh et al., 2014; Li et al., 2016). It is shown
that GAA repeats are able to impede transcription elongation
(Krasilnikova et al., 2007; Ohshima et al., 1998) and the DNA
replication fork (Krasilnikova and Mirkin, 2004) in vitro or in
plasmid-based model systems in vivo. Also, R-loops formed at
the expanded GAA tracts could block elongation of RNA poly-
merase II (Pol II) as well as the replication machinery. However,
until now it was not possible to determine whether the GAA re-
peats in FRDA cells stall the replication machinery and could
block FXN transcription in vivo at the endogenous locus. A
stalled replication fork could lead to fork reversal, double-strand
break formation, andDNA polymerase slippage, resulting in GAA
repeat expansions (Mirkin, 2007).
Besides replication fork stalling, studies in model systems
have shown that GAA repeat instability could depend on the
orientation of replication fork movement through the repeats
(Rindler et al., 2006). Several models have been proposed where
activation or deactivation of replication origins changes their po-
sition and distance relative to the repeat tract (origin switch and
origin shift model), which influences the replication fork direction
through the repeats. In addition, altered replication fork progres-
sion (fork shift model) could play an important role in the mech-
anism leading to repeat expansion or contraction (Mirkin, 2007).
However, it still has to be revealed which of thesemodels applies(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. The DNA Replication Program Is Altered at the Endogenous FXN Locus in FRDA iPSCs
(A) Schematic of the steps of SMARD that enable visualization of single-replicating DNA molecules (adapted from Gerhardt et al., 2014a). First, cells are pulsed
with IdU (red) and CldU (green) and then embedded in agarose and lysed. After digestion with the PmeI enzyme, DNAmolecules are separated by pulsed-field gel
electrophoresis (PFGE). Next the DNA segment containing the FXN locus is identified, excised from the gel, and stretched on silanized glass slides. The labeled
DNA molecules are detected by immunostaining (red and green), and two FISH probes surrounding the repeats are used to orient the FXN locus.
(legend continued on next page)
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to GAA repeat expansion and whether replication forks stall at
the FXN locus in FRDA cells.
We determined that errors in the DNA replication program can
affect GAA repeat expansion in FRDA iPSCs at the endogenous
FXN locus. Using single-molecule analysis of replicated DNA
(SMARD), we observed a significant stalling of replication forks
at the expanded GAA repeats, along with aberrant replication
origin activation and altered replication fork direction through
the repeats at the FXN locus in FRDA iPSCs and fibroblasts.
The magnitude of replication fork stalling described herein
has not been previously reported in human cells. Treatment of
FRDA iPSCs with a GAA-specific polyamide, which prevents
GAA triplex formation in vitro and stabilizes GAA repeats in vivo
(Du et al., 2012), released fork stalling. This result implicates
replication fork stalling at GAA triplexes in the repeat expansion
mechanism in FRDA patient cells.
RESULTS
The DNA Replication Program Is Altered at the
Endogenous FXN Locus in FRDA iPSCs
In vitro models predict that repeat expansion is caused by DNA
polymerase slippage at stalled replication forks (Mirkin, 2007).
Using a plasmid-based model system, it has been shown that
the replication fork stalls at expanded GAA repeats (Chandok
et al., 2012; Krasilnikova and Mirkin, 2004) and that altered repli-
cation fork progression results in repeat instability (Cleary et al.,
2002; Pelletier et al., 2003; Rindler et al., 2006; Shishkin et al.,
2009). It is still unknown, however, how the replication fork pro-
ceeds through the endogenous FXN locus in the native chro-
matin environment and whether the replication machinery stalls
at the GAA repeats in FRDA cells. To determine the replication
program at the endogenous FXN locus, we employed SMARD
(Figure 1A) (Gerhardt et al., 2014a; Norio and Schildkraut,
2001). We analyzed the replication profile of a 146-kb genomic
DNA segment containing the FXN gene and flanking sequence
recognized by two fluorescence in situ hybridization (FISH)
probes (detecting a short and a long DNA fragment at either
end of the segment) in two unaffected control and two FRDA
iPSC lines (FRDA1: GM04078: 577 and 743 GAA repeats and
FRDA2: GM03665 containing 874 and 1,254 GAA repeats at
passage 6 after reprogramming; Figure 1B). FRDA iPSCs exhibit
decreased FXN transcript levels and expanding GAA repeats (Ku
et al., 2010) (Figures S1A and S1B). Flow cytometry analyses
showed that the FRDA iPSC and control iPSC lines have similar
cell-cycle profiles (Figures S1C and S1D).
First, we asked whether the GAA repeats were replicated
differently in FRDA iPSCs compared to unaffected control iPSCs
(Figures 1C–1F). In unaffected iPSCs (controls 1 and 2), the repli-
cation fork moved from both directions through the GAA repeats
(Figures 1C and 1D). We detected DNA molecules with replica-(B) The repeat lengths in two unaffected (C1 and 2) and two FRDA (FRDA1 and 2
(C–F) Top (also shown in Figures 3 and 4): map of the PmeI segment containing th
blue and the GAA repeats are indicated by a red vertical bar. Middle: photomicrog
FRDA2 (F) iPSCs are ordered according to replication fork (yellow arrows) progress
asterisks mark the replication initiation sites (also shown in Figures 3 and 4). Botto
from the DNA molecules shown above. Results of cell cycle, FXN mRNA quantit
1220 Cell Reports 16, 1218–1227, August 2, 2016tion forks progressing from either the 50-30 or 30-50 direction or
both directions. Very few replication origins (2.5% of all mole-
cules) were seen at the FXN locus in unaffected iPSCs. In
contrast, we detected a significantly altered replication program
in FRDA iPSCs, with replication forks progressing predominantly
in the 30-50 direction through the FXN locus and GAA repeats
(Figures 1E and 1F). In addition, we detected increased replica-
tion initiation at the FXN locus. Replication origins were detected
in 12.3% of molecules in FRDA1 iPSCs and in 18.3% of mole-
cules in FRDA2 iPSCs. Replication origins were activated mostly
downstream of the repeats in the FXN gene, which increases the
number of replication forks progressing in the 30-50 direction
through the repeats. In FRDA fibroblasts, from which FRDA1
iPSCs were derived, we observed a similar replication profile
as in FRDA iPSCs (Figures S2A and S2B), suggesting that altered
replication fork progression through the repeats could lead to
repeat expansion in FRDA patient cells.
In iPSCs harboring one expanded and one short GAA tract,
progressive expansions occur exclusively within the long GAA
repeats, identifying the length threshold as a key determinant
of the expansions (Ku et al., 2010). Additionally, repeat expan-
sion takes place solely at the disease locus, indicating that spe-
cific cis elements are crucial for the mechanism. Therefore, the
length of the repeat tract together with activation or inactivation
of local replication origins, which alter fork progression, are the
primary determinants of the repeat expansion (Gerhardt et al.,
2014b). These cis elements accompanied by the activities of
trans factors, such as mismatch repair protein Msh2, facilitate
GAA repeat expansions (Du et al., 2012; Ku et al., 2010). To sepa-
rate the effect of cis elements from potential cell-specific differ-
ences in trans factors, we determined the replication profile
in FRDA iPSCs containing one expanded allele and one allele
with a short, stable GAA repeat tract (FRDA P iPSCs; Figures
S2A and S2C). As anticipated, we observed a mixed replication
profile in FRDA P iPSCs, with replication forks progressing from
both directions through the repeats, similar to unaffected iPSCs,
and an increase in replication origins (16% of molecules) at the
FXN gene, similar to FRDA iPSCs (Figure S2C). These results
show that two different replication programs, presenting in
SMARD analyses as a mixed profile, are governed by the length
of the GAA tract and co-exist in cells heterozygous for the GAA
repeat expansion.
Replication Forks Stall at the GAA Repeats in FRDA
iPSCs
Replication forks stall in both directions at the GAA repeats when
replicated as episomal DNA in human cells (Follonier and Lopes,
2014; Krasilnikova and Mirkin, 2004). To determine whether
stalling occurs at the endogenous FXN locus, we divided the
FXN segment into 5-kb intervals, and we counted the replica-
tion forks that proceed through each 5-kb interval. Our results) iPSC lines were determined by PCR.
e FXN gene and GAA repeats. The positions of the FISH probes are marked in
raphs of labeled DNAmolecules from control 1 (C), control 2 (D), FRDA1 (E), and
ion in the 50-30 and 30-50 directions, replication initiation, and termination. White
m: the percentage of molecules with IdU incorporation (first pulse) is calculated
ation, and repeat expansion analyses in FRDA iPSCs are shown in Figure S1.
Figure 2. Replication Forks Stall at the GAA Repeats in FRDA Cells
(A–C) The percentage of molecules with replication forks for each 5-kb DNA
interval was calculated at the FXN locus in unaffected iPSCs (controls 1 and 2)
(A), FRDA iPSCs (FRDA1 and 2) (B), and FRDA fibroblasts and FRDA iPSCs
carrying one expanded and one short GAA allele (FRDA P) (C). SMARD profiles
are shown in Figure S2.show no significant replication fork stalling at the GAA repeats in
two control iPSC lines (Figure 2A). In contrast, in FRDA iPSCs,
replication fork stalling was detected at the expanded GAA
repeats (Figure 2B). FRDA2 iPSCs with longer GAA repeats
showed slightly more stalled replication forks (25% of mole-
cules) than FRDA1 iPSCs with shorter repeats (21.5%). While
we observed replication fork stalling in both directions (Figures
1E and 1F), a major block of the replication machinery occurred
at the repeats in the 30-50 direction. We also detected replication
fork stalling in FRDA P iPSCs (14.6% of molecules) and FRDA
fibroblasts (18.7% of molecules, Figure 2C). These results
show that the replication machinery encounters obstacles at
the endogenous FXN locus or that it collides with the Pol II tran-
scription complex.
Replication Origins Are Developmentally Regulated at
the FXN Locus
Next, we determined whether the replication origins are acti-
vated in response to the stalled fork or if activation of origins
and increased number of replication forks progressing in the
30-50 direction cause fork stalling. As the replication origins in
FRDA iPSCs seem to be activated in a false direction to rescue
stalled replication forks, we were interested to establish whether
these replication origins are dormant rescue origins or more
likely developmentally regulated origins.
To this end, we examined the replication program at the FXN
locus in unaffected human embryonic stem cells (hESCs) by
SMARD. Because it has been shown that the position and num-
ber of replication initiation sites can change during cell fate
determination (Gray et al., 2007; Norio et al., 2005), we decided
to analyze the DNA replication at the FXN locus before and after
hESC differentiation. We observed 20% of molecules with
replication initiation sites at the FXN locus in two hESC lines
(hESC1 [H9] and hESC2 [H14]) (Figures 3A and 3B; Figure S3A).
The replication origins were located downstream of the repeats
at the FXN gene (Figures 3A and 3B). In addition, the replication
forks progressed in both directions through the FXN locus
at normal speeds without fork stalling in each of these lines
(Figures S3B and S3C). After differentiation of hESCs to
neurospheres, we detected only a single initiation event and
replication forks progressing from both directions through the
repeats (Figure 3C). The replication profile in these differentiated
cells more closely resembles the replication profile of the FXN
locus in control iPSCs rather than that of the undifferentiated
hESCs (Figures 1C, 1D, and 3). These results show that replica-
tion origins in the FXN gene do not fire after cell differentiation
and that reprogramming of the replication profile at the FXN
locus in unaffected iPSCs was incomplete. In summary, the
presence of active replication origins at the FXN locus in
undifferentiated hESCs, but not differentiated cells, confirms
that replication origins at the FXN locus are developmentally
regulated.
Replication Origins Are Activated Upstream and
Downstream of the Repeats in Unaffected Cells but Not
FRDA iPSCs
Because origin placement influences the direction of replication
fork movement through the GAA repeats, we next investigatedCell Reports 16, 1218–1227, August 2, 2016 1221
whether and where replication origins are activated at the FXN
gene after induction of replicative stress by inhibition of the
DNA polymerase and replication machinery (Anglana et al.,
2003; Doksani et al., 2009). It has been shown that, in response
to replicative stress including fork stalling, dormant origins are
activated to rescue the stalled replication fork. After treatment
of control iPSCs with aphidicolin, an inducer of replicative stress
(Figure 3D), we observed a slower replication fork progression
probably caused by replication fork pausing (Figures S3C and
S3D). As expected, to counteract disrupted replication fork pro-
gression, we detected activation of dormant replication origins in
25% of DNA molecules (Figures 3D and 3E). These replication
origins were activated in control iPSCs in the FXN gene down-
stream of the repeat region at locations similar to those found
in FRDA iPSCs (Figures 1E and 1F). However, in contrast to
FRDA iPSCs, in control cells the replication forks progressed
from both directions through the repeats after induction of repli-
cative stress and replication fork pausing. These results indicate
that, under replicative stress, replication origins are activated not
only downstream of the repeats in the FXN gene but also up-
streamof the FXN gene in cells lacking the expandedGAA repeat
tract.
In plasmid-based experiments, an increase in instability of
particular expansions was detected when TTC repeats were
located on the lagging-strand template (30-50 direction at the
endogenous locus) (Rindler et al., 2006). To determine an
accurate direction of the replication fork, we calculated the per-
centage of molecules with replication forks progressing through
the GAA repeats in either the 50-30 or 30-50 direction in control
hESCs, control iPSCs, FRDA iPSCs, and FRDA fibroblasts (Fig-
ure 3F). Quantification of directionality through the repeat region
showed that, in control cell lines, the replication fork moved from
both directions, with a slight bias toward progression in the 30-50
direction. In control iPSCs treated with aphidicolin, more replica-
tion forks progressed in the 50-30 direction. However, a signifi-
cant alteration in the replication fork direction was only detected
in FRDA cell lines, with most of the replication forks moving
through theGAA repeats in a 30-50 direction (Figure 3F). These re-
sults suggest that, in FRDA cells, the stalled replication fork is
not rescued by activation of dormant origins upstream of the
repeats and, instead, activation of origins downstream of the
repeats leads to preferential progression of DNA polymerase in
the 30-50 direction. This altered replication fork progression and
stalling in the 30-50 direction could promote repeat expansion
and lead to collision with the transcription machinery at the
endogenous FXN locus.
GAA-Specific Polyamide Treatment Releases
Replication Fork Stalling in FRDA iPSCs
A released replication block should alleviate GAA repeat expan-
sion as well as minimize collision between transcription and
replication machineries. We wanted to know if treatment of
FRDA iPSCs with a GAA-specific polyamide (FA1) (Figure 4B),
which is known to inhibit triplex formation in vitro (Burnett
et al., 2006; Du et al., 2012), would release the stalled replication
fork at the GAA repeats at the endogenous FXN locus in vivo. It
was shown that this beta-alanine-linked polyamide prevents
GAA repeat expansion in FRDA iPSCs (Du et al., 2012) and in-1222 Cell Reports 16, 1218–1227, August 2, 2016creases FXN transcription in FRDA cells (Burnett et al., 2006).
However, it is not clear yet how this compound exactly leads
to stabilization of the GAA repeats in FRDA iPSCs. It has been
suggested that GAA-specific polyamides could prevent the for-
mation of DNA triplexes in vivo at the endogenous FXN locus
and, thus, avoid polymerase stalling (Burnett et al., 2006).
To test whether a GAA-specific polyamide can prevent the
replication fork stall in vivo at the FXN locus, we treated FRDA
iPSCs for 48 hr with compound FA1 and analyzed the replication
program in these cells by SMARD. Although we observed a
similar replication profile in both treated and non-treated cells
(Figures 4A and 4B), in FRDA iPSCs treated with FA1 we found
no significant replication fork stalling at the GAA repeats in
contrast to non-treated FRDA iPSCs (Figures 4C and 4D).
Thus, these results show that the GAA-specific FA1 polyamide
indeed released the replication fork stalling in FRDA iPSCs (Fig-
ure 4D). In addition, replication initiation was unchanged upon
FA1 treatment of FRDA iPSCs (Figures 4A and 4B; Figure S3E).
In summary, our results show that culturing FRDA iPSCs with a
GAA-specific polyamide, which alleviates formation of second-
ary GAA repeat structures, released the observed replication
impediment in FRDA iPSCs. The release of replication fork stall-
ing by FA1 could explain the observed stabilization of the
expanded GAA repeats in FRDA iPSCs (Du et al., 2012).
DISCUSSION
Several inherited repeat expansion disorders like FRDA, fragile X
syndrome (FXS), myotonic dystrophy (DM1), Huntington’s dis-
ease, and spinocerebellar ataxia type 7 (SCA7) are caused by ex-
pansions of trinucleotide repeat sequences (Iyer et al., 2015). We
examined the DNA replication program in FRDA patient cells to
determine if defects in DNA replication processes cause GAA
repeat expansions. We found that replication fork progression
at the FXN gene is altered in FRDA cells to a much greater extent
than the replication impediment we previously detected at the
FMR1 locus in unaffected and FXS hESCs using SMARD (Ger-
hardt et al., 2014a, 2014b). The major stall detected in FRDA
cells suggests that the replication fork indeed encounters a block
imposed by stable non-canonical DNA structures (e.g., triplexes)
formed by expandedGAA repeats at the endogenous FXN locus.
The replication fork also could encounter paused transcription
machinery in FRDA cells and R-loop structures. Our observation
of a released replication fork block after treatment with a DNA-
binding GAA-specific polyamide suggests that stable GAA
DNA triplex conformations are responsible for replication fork
stalling in FRDA cells.
We also found that the directionality of the replication fork
was altered in FRDA cells. In unaffected cells, which have short
GAA repeats that lack the propensity for non-canonical DNA
structure or R-loop formation, replication forks progressed
from both directions through the endogenous FXN locus, which
could lead to a balance between contraction and expansion
events that stabilize the short GAA repeats. In contrast, in
FRDA cells harboring expanded GAA repeats, we observed
fork progression predominantly in the 30-50 direction, which, in
conjunction with a higher probability for secondary structure
formation, could promote repeat expansion. In plasmid-based
(legend on next page)
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model systems, replication fork progression from 50-30 through
GAA repeats led to repeat contraction and expansion. How-
ever, replication forks progressing from the 30-50 direction
(TTC sequence as the template for lagging-strand synthesis)
mostly resulted in repeat expansion (Rindler et al., 2006). We
postulate that in FRDA iPSCs the replication fork direction is
switched due to the activation of proximal replication origins
downstream of the repeats. Replication forks progressing
from the 50-30 direction (upstream of the repeats) rarely reach
the expanded GAA repeat region in FRDA cells, as these repli-
cation forks originate from replication origins located farther
away from the repeat tract than the newly activated replication
origins in FRDA cells. Our results confirm findings from plasmid-
based experiments that a switch in the replication fork direction
occurs at the endogenous FXN locus (Figure S4), which could
facilitate the observed GAA repeat expansion in FRDA iPSCs.
The FRDA fibroblasts exhibit a similar replication program to
FRDA iPSCs, with replication forks predominantly progressing
in a 30-50 direction through theGAA repeats. However, in contrast
to FRDA iPSCs, the expanded repeats are relatively stable in
FRDA fibroblasts (Figure S2A). Stability of the GAA repeats could
be explained by lack of additional trans factors necessary for
repeat instability, such as Msh2, which have been shown to
bind in close proximity to the repeats and facilitate repeat expan-
sion in FRDA iPSCs (Ku et al., 2010). Human pluripotent stem
cells express increased levels of Msh2, and its downregulation
leads to a significant alleviation of expansion rates (Du et al.,
2012; Gerhardt, 2015; Ku et al., 2010). However, increased
Msh2 level is not sufficient to cause repeat instability, as in
FRDA P iPSCs where the FXN allele of normal repeat length
does not expand while the allele with the long GAA tract does.
Thus, co-existence of both the appropriate cis environment
(structure-forming expanded repeats and replication origins)
and trans factors (high expression levels of MMR proteins) is
necessary for expansions to occur.
Our results suggest that the altered replication fork direction is
caused by a failure to activate the proper dormant origins to
rescue the stalled forks at the FXN locus in FRDA iPSCs. It is
not known which factors or elements lead to origin activation
or deactivation in human cells (Me´chali, 2010). Under replicative
stress and fork-stalling conditions induced by aphidicolin treat-
ment, replication forks progress bidirectionally in unaffected
cells, indicating that replication initiation events take place
both upstream and downstream of the repeats. In FRDA cells,
however, the majority of replication forks progress only in the
30-50 direction, originating from initiation sites downstream of
the GAA repeats. A similar phenomenon of unidirectional forkFigure 3. Replication Origins Are Developmentally Regulated and Are
iPSCs after Induction of Replicative Stress
(A–D) Photomicrographs of labeled DNA molecules from unaffected hESCs1 (H9)
with aphidicolin (D) are ordered according to replication fork (yellow arrows) prog
Bottom: the percentage of molecules with IdU incorporation (first pulse) is calcu
(E) Graph shows the percentage of DNA molecules with replication initiation site
aphidicolin, and FRDA iPSCs.
(F) The percentage of DNAmolecules with replication forks progressing through th
hESCs, differentiated cells, control iPSCs (with and without aphidicolin treatment),
well as replication fork quantitation and speed calculations with and without aph
1224 Cell Reports 16, 1218–1227, August 2, 2016movement through the CGG repeats at the FMR1 locus was
observed in FXS hESCs (Gerhardt et al., 2014a, 2014b).
However, inactivation of a replication origin upstream of the
expandedCGG repeats by a point mutation was required to elicit
the alteration in replication fork direction in FXS hESCs. Replica-
tion initiation was unchanged upon FA1 treatment of FRDA
iPSCs (Figures 4A and 4B; Figure S3E). These results suggest
that replication origin activation in FRDA iPSCs might not be
due to replication fork stalling, but rather an independent event
causing replication fork progression in a 30-50 direction that
drives repeat expansion in FRDA cells. However, further experi-
ments are needed to test this theory.
Besides DNA sequence, changes in chromatin modifications
could impact origin activation (Dorn and Cook, 2011; Rivera
et al., 2014). At the FXN locus, origins are active in unaffected
hESCs with unperturbed FXN transcription and a euchromatic
environment as well as in FRDA cells having the FXN locus
in a heterochromatic state and decreased FXN transcription.
These results show that epigenetic modifications associated
with neither transcription initiation nor active transcription itself
are likely to account for differences in origin firing between
FRDA and control cells. Besides epigenetic marks and local
chromatin structure, chromatin looping, nuclear position, and
binding of specific trans factors could influence origin de/activa-
tion (Marks et al., 2016). Although preferential localization of
expanded GAA-FXN loci to the nuclear lamina was discovered
recently (Silva et al., 2015), such analyses have not been con-
ducted in pluripotent cells.
It remains to be determined whether the replication machinery
runs into co-transcriptional R-loops or if the transcription com-
plex collides with the stalled replication machinery at the unre-
solved DNA structures stabilized by DNA-binding proteins (Du
et al., 2012; Ku et al., 2010). Recently it was shown that preven-
tion of R-loop formation increases FXN transcription in FRDA
fibroblasts (Li et al., 2016). The contributions of triplexes and
R-loops to expansion and transcription may vary between cell
types depending on the availability of trans factors. This could
explain the different levels of FXN gene transcription in FRDA
cells with similar levels of fork stalling. It also has been proposed
that R-loops at GAA repeats may stimulate formation of DNA tri-
plexes, as RNA-DNA hybrids render one of the DNA strands sin-
gle stranded and capable of interaction with double-stranded
DNA (dsDNA) to form a stable triple helical conformation (Grabc-
zyk and Usdin, 2000). Head-on collision between transcription
and replication machineries has been recurrently linked to ge-
netic instability and chromosomal rearrangements; therefore, it
is likely that repeat expansions are stimulated by the temporaryActivated Upstream and Downstream of the Repeats in Unaffected
(A), hESCs2 (H14) (B), differentiated H9 cells (C), and unaffected iPSCs treated
ression in the 50-30 and 30–50 directions, replication initiation, and termination.
lated from the DNA molecules shown above.
s in unaffected hESCs, differentiated cells, unaffected iPSCs with or without
e GAA repeats at the FXN locus either in the 30-50 or 50-30 direction in unaffected
and FRDA iPSCs and fibroblasts. Results of hESC pluripotency assessment as
idicolin treatment are given in Figure S3.
Figure 4. Stalled Replication Forks at the GAA Repeats in FRDA iPSCs Are Released by Polyamide Treatment
(A and B) Photomicrographs of labeled DNAmolecules from FRDA iPSCs incubated with PBS (A) or polyamide FA1 (B). Bottom: the percentage of molecules with
IdU incorporation (first pulse) is calculated from the DNAmolecules shown above. (B, right) Polyamide structure of FA1: b-alanine (b)-linked Pyrrole (Py)-Imidazole
(Im)-dimethylaminopropylamine (Dp) and a model depicting the linear FA1 polyamide binding in a C-terminal to N-terminal orientation with respect to 50- to -30
sequence of the GAA repeat target in the minor groove are shown.
(C and D) The percentage of molecules with replication forks for each 5-kb DNA interval was counted at the FXN locus in FRDA iPSCs incubated with PBS (C) or
polyamide FA1 (D). A model depicting the basis for altered replication fork movement at the FXN locus in FRDA cells is shown in Figure S4.conflict between replication and transcription at the expanded
GAAs.
In summary, our data demonstrate that the replicationmachin-
ery stalls at the endogenous expanded GAA repeats in the FXN
genewhile progressing in the30-50direction.Replication fork stall-
ing may result in DNA polymerase slippage and stimulate the
progressive repeat expansions seen in FRDA iPSCs. Moreover,
our results show that the GAA-specific polyamide FA1 releases
replication fork stalling at the GAA repeats in FRDA iPSCs, sug-
gesting that expanded repeats may indeed form triplexes at theendogenous FXN locus that impede the replication complexes.
Thus, compounds capable of alleviating replication fork stalling
can be of therapeutic significance in the treatment of FRDA.EXPERIMENTAL PROCEDURES
Cell Culture
Control 1 and FRDA 1 and FRDA 2 fibroblasts were obtained from Coriell Cell
repositories (lines GM08399, GM04078, and GM03665, respectively). Control
2 and FRDA P fibroblasts (lines C2 and 4491, respectively) were derived fromCell Reports 16, 1218–1227, August 2, 2016 1225
skin biopsies conducted at Children’s Hospital of Philadelphia (CHOP) accord-
ing to approved institutional review board (IRB) protocols, as described in Li
et al. (2015a). Detailed culturing, differentiation, and reprogramming protocols
can be found in the Supplemental Experimental Procedures.
Flow Cytometry
Antibodies against SSEA-3, SSEA-4, OCT4, SOX2, PAX6, PLZF, and TRA-1-
60 were used to assess iPSC and hESC pluripotency. Antibody information
and detailed protocols are provided in the Supplemental Experimental
Procedures.
Determining Number of GAA Repeats and FXN mRNA Expression
PCR analyses of the GAA repeat number were conducted using two sets of
primers FXN_short (forward and reverse; 498 bp of the GAA repeats flanking
sequences) and FXN_long (forward and reverse; 1,370 bp of the GAA repeats
flanking sequences), exactly as described in Li et al. (2015b). All qRT-PCR
analyses were conducted using the Power SYBR Green RNA-to-CT 1-Step
Kit (7500 Fast Real Time–PCR System, Applied Biosystems), according to Li
et al. (2015a).
SMARD
The complete SMARD protocol is described in the Supplemental Experimental
Procedures.
Statistical Analyses
Statistical analyses were conducted using GraphPad Prism 6. Statistical sig-
nificance was determined by performing Student’s t test and p < 0.05 was
considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2016.06.075.
AUTHOR CONTRIBUTIONS
J.G. andM.N. conceived and designed the study. J.G., A.D.B., and J.S.B. per-
formed the experiments and analyzed the results. P.B.D. and J.W.P. gener-
ated and provided the polyamide. J.G., J.S.B., andM.N. wrote themanuscript.
A.D.B. and Z.R. edited the manuscript.
ACKNOWLEDGMENTS
This work was supported by the Rose F. Kennedy Intellectual and Develop-
mental Disabilities Research Center (P30 HD071593) Pilot and Feasibility
Award and Grant (to J.G.), NIH grant 7R01NS081366 from the National Insti-
tute of Neurological Disorders and Stroke and Polish National Science Center
Grant 2015/19/B/NZ1/02804 (to M.N.), and Friedreich’s Ataxia Research Alli-
ance and FARA Ireland (to M.N. and J.S.B.). We thank Drs. Sharon Dent (UT
MD Anderson Cancer Center), Joel Gottesfeld (The Scripps Research Insti-
tute), and Dr. Urszula Polak for helpful comments and support in preparation
of this work.
Received: March 31, 2016
Revised: May 31, 2016
Accepted: June 17, 2016
Published: July 14, 2016
REFERENCES
Anglana, M., Apiou, F., Bensimon, A., and Debatisse, M. (2003). Dynamics of
DNA replication in mammalian somatic cells: nucleotide pool modulates origin
choice and interorigin spacing. Cell 114, 385–394.
Burnett, R., Melander, C., Puckett, J.W., Son, L.S., Wells, R.D., Dervan, P.B.,
andGottesfeld, J.M. (2006). DNA sequence-specific polyamides alleviate tran-1226 Cell Reports 16, 1218–1227, August 2, 2016scription inhibition associated with long GAA.TTC repeats in Friedreich’s
ataxia. Proc. Natl. Acad. Sci. USA 103, 11497–11502.
Campuzano, V., Montermini, L., Molto`, M.D., Pianese, L., Cosse´e, M., Caval-
canti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al. (1996). Frie-
dreich’s ataxia: autosomal recessive disease caused by an intronic GAA triplet
repeat expansion. Science 271, 1423–1427.
Chandok, G.S., Patel, M.P., Mirkin, S.M., and Krasilnikova, M.M. (2012).
Effects of Friedreich’s ataxia GAA repeats on DNA replication in mammalian
cells. Nucleic Acids Res. 40, 3964–3974.
Cleary, J.D., Nichol, K., Wang, Y.H., and Pearson, C.E. (2002). Evidence of cis-
acting factors in replication-mediated trinucleotide repeat instability in primate
cells. Nat. Genet. 31, 37–46.
De Biase, I., Rasmussen, A., Endres, D., Al-Mahdawi, S., Monticelli, A.,
Cocozza, S., Pook, M., and Bidichandani, S.I. (2007). Progressive GAA expan-
sions in dorsal root ganglia of Friedreich’s ataxia patients. Ann. Neurol. 61,
55–60.
De Michele, G., Cavalcanti, F., Criscuolo, C., Pianese, L., Monticelli, A., Filla,
A., and Cocozza, S. (1998). Parental gender, age at birth and expansion length
influence GAA repeat intergenerational instability in the X25 gene: pedigree
studies and analysis of sperm from patients with Friedreich’s ataxia. Hum.
Mol. Genet. 7, 1901–1906.
Delatycki, M.B., Williamson, R., and Forrest, S.M. (2000). Friedreich ataxia: an
overview. J. Med. Genet. 37, 1–8.
Doksani, Y., Bermejo, R., Fiorani, S., Haber, J.E., and Foiani, M. (2009). Repli-
con dynamics, dormant origin firing, and terminal fork integrity after double-
strand break formation. Cell 137, 247–258.
Dorn, E.S., and Cook, J.G. (2011). Nucleosomes in the neighborhood: new
roles for chromatin modifications in replication origin control. Epigenetics 6,
552–559.
Du, J., Campau, E., Soragni, E., Ku, S., Puckett, J.W., Dervan, P.B., and
Gottesfeld, J.M. (2012). Role of mismatch repair enzymes in GAA$TTC
triplet-repeat expansion in Friedreich ataxia induced pluripotent stem cells.
J. Biol. Chem. 287, 29861–29872.
Follonier, C., and Lopes, M. (2014). Combined bidimensional electrophoresis
and electron microscopy to study specific plasmid DNA replication intermedi-
ates in human cells. Methods Mol. Biol. 1094, 209–219.
Gerhardt, J. (2015). Epigenetic modifications in human fragile X pluripotent
stem cells; Implications in fragile X syndrome modeling. Brain Res. S0006-
8993(15)00741-6. http://dx.doi.org/10.1016/j.brainres.2015.10.004.
Gerhardt, J., Tomishima, M.J., Zaninovic, N., Colak, D., Yan, Z., Zhan, Q.,
Rosenwaks, Z., Jaffrey, S.R., and Schildkraut, C.L. (2014a). The DNA replica-
tion program is altered at the FMR1 locus in fragile X embryonic stem cells.
Mol. Cell 53, 19–31.
Gerhardt, J., Zaninovic, N., Zhan, Q., Madireddy, A., Nolin, S.L., Ersalesi, N.,
Yan, Z., Rosenwaks, Z., and Schildkraut, C.L. (2014b). Cis-acting DNA
sequence at a replication origin promotes repeat expansion to fragile X full
mutation. J. Cell Biol. 206, 599–607.
Grabczyk, E., and Usdin, K. (2000). The GAA*TTC triplet repeat expanded in
Friedreich’s ataxia impedes transcription elongation by T7 RNA polymerase
in a length and supercoil dependent manner. Nucleic Acids Res. 28, 2815–
2822.
Gray, S.J., Gerhardt, J., Doerfler, W., Small, L.E., and Fanning, E. (2007). An
origin of DNA replication in the promoter region of the human fragile X mental
retardation (FMR1) gene. Mol. Cell. Biol. 27, 426–437.
Groh, M., Lufino, M.M., Wade-Martins, R., and Gromak, N. (2014). R-loops
associated with triplet repeat expansions promote gene silencing in Friedreich
ataxia and fragile X syndrome. PLoS Genet. 10, e1004318.
Iyer, R.R., Pluciennik, A., Napierala, M., and Wells, R.D. (2015). DNA triplet
repeat expansion and mismatch repair. Annu. Rev. Biochem. 84, 199–226.
Koeppen, A.H. (2011). Friedreich’s ataxia: pathology, pathogenesis, and mo-
lecular genetics. J. Neurol. Sci. 303, 1–12.
Krasilnikova, M.M., and Mirkin, S.M. (2004). Replication stalling at Friedreich’s
ataxia (GAA)n repeats in vivo. Mol. Cell. Biol. 24, 2286–2295.
Krasilnikova, M.M., Kireeva, M.L., Petrovic, V., Knijnikova, N., Kashlev, M., and
Mirkin, S.M. (2007). Effects of Friedreich’s ataxia (GAA)n*(TTC)n repeats on
RNA synthesis and stability. Nucleic Acids Res. 35, 1075–1084.
Ku, S., Soragni, E., Campau, E., Thomas, E.A., Altun, G., Laurent, L.C., Loring,
J.F., Napierala, M., and Gottesfeld, J.M. (2010). Friedreich’s ataxia induced
pluripotent stem cells model intergenerational GAA,TTC triplet repeat insta-
bility. Cell Stem Cell 7, 631–637.
Li, Y., Lu, Y., Polak, U., Lin, K., Shen, J., Farmer, J., Seyer, L., Bhalla, A.D., Roz-
wadowska, N., Lynch, D.R., et al. (2015a). Expanded GAA repeats impede
transcription elongation through the FXN gene and induce transcriptional
silencing that is restricted to the FXN locus. Hum. Mol. Genet. 24, 6932–6943.
Li, Y., Polak, U., Bhalla, A.D., Rozwadowska, N., Butler, J.S., Lynch, D.R.,
Dent, S.Y., and Napierala, M. (2015b). Excision of Expanded GAA Repeats
Alleviates the Molecular Phenotype of Friedreich’s Ataxia. Mol. Ther. 23,
1055–1065.
Li, L., Matsui, M., and Corey, D.R. (2016). Activating frataxin expression by
repeat-targeted nucleic acids. Nat. Commun. 7, 10606.
Marks, A.B., Smith, O.K., and Aladjem, M.I. (2016). Replication origins: deter-
minants or consequences of nuclear organization? Curr. Opin. Genet. Dev. 37,
67–75.
Me´chali, M. (2010). Eukaryotic DNA replication origins: many choices for
appropriate answers. Nat. Rev. Mol. Cell Biol. 11, 728–738.
Mirkin, S.M. (2007). Expandable DNA repeats and human disease. Nature 447,
932–940.
Norio, P., and Schildkraut, C.L. (2001). Visualization of DNA replication on in-
dividual Epstein-Barr virus episomes. Science 294, 2361–2364.
Norio, P., Kosiyatrakul, S., Yang, Q., Guan, Z., Brown, N.M., Thomas, S.,
Riblet, R., and Schildkraut, C.L. (2005). Progressive activation of DNA replica-tion initiation in large domains of the immunoglobulin heavy chain locus during
B cell development. Mol. Cell 20, 575–587.
Ohshima, K., Montermini, L., Wells, R.D., and Pandolfo, M. (1998). Inhibitory
effects of expanded GAA.TTC triplet repeats from intron I of the Friedreich
ataxia gene on transcription and replication in vivo. J. Biol. Chem. 273,
14588–14595.
Pelletier, R., Krasilnikova, M.M., Samadashwily, G.M., Lahue, R., and Mirkin,
S.M. (2003). Replication and expansion of trinucleotide repeats in yeast.
Mol. Cell. Biol. 23, 1349–1357.
Rindler, M.P., Clark, R.M., Pollard, L.M., De Biase, I., and Bidichandani, S.I.
(2006). Replication in mammalian cells recapitulates the locus-specific differ-
ences in somatic instability of genomic GAA triplet-repeats. Nucleic Acids Res.
34, 6352–6361.
Rivera, C., Gurard-Levin, Z.A., Almouzni, G., and Loyola, A. (2014). Histone
lysine methylation and chromatin replication. Biochim. Biophys. Acta 1839,
1433–1439.
Schmucker, S., and Puccio, H. (2010). Understanding the molecular mecha-
nisms of Friedreich’s ataxia to develop therapeutic approaches. Hum. Mol.
Genet. 19 (R1), R103–R110.
Shishkin, A.A., Voineagu, I., Matera, R., Cherng, N., Chernet, B.T., Krasilni-
kova, M.M., Narayanan, V., Lobachev, K.S., and Mirkin, S.M. (2009). Large-
scale expansions of Friedreich’s ataxia GAA repeats in yeast. Mol. Cell 35,
82–92.
Silva, A.M., Brown, J.M., Buckle, V.J., Wade-Martins, R., and Lufino, M.M.
(2015). Expanded GAA repeats impair FXN gene expression and reposition
the FXN locus to the nuclear lamina in single cells. Hum. Mol. Genet. 24,
3457–3471.
Wells, R.D. (2008). DNA triplexes and Friedreich ataxia. FASEB J. 22, 1625–
1634.Cell Reports 16, 1218–1227, August 2, 2016 1227
